Cargando…

Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation

INTRODUCTION: Burkholderia cepacia is an aerobic, Gram-negative bacillus, which exhibits innate resistance to multiple antibiotics and disinfectants. Although it is a chronic colonizer of the respiratory tract, it may rarely present with fatal necrotizing pneumonia-like features in immunosuppressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Sufyan, Madigubba, Haritha, N, Himanshu Y., Chawla, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208758/
https://www.ncbi.nlm.nih.gov/pubmed/34151173
http://dx.doi.org/10.1099/acmi.0.000222
_version_ 1783708984801230848
author Ibrahim, Sufyan
Madigubba, Haritha
N, Himanshu Y.
Chawla, Kiran
author_facet Ibrahim, Sufyan
Madigubba, Haritha
N, Himanshu Y.
Chawla, Kiran
author_sort Ibrahim, Sufyan
collection PubMed
description INTRODUCTION: Burkholderia cepacia is an aerobic, Gram-negative bacillus, which exhibits innate resistance to multiple antibiotics and disinfectants. Although it is a chronic colonizer of the respiratory tract, it may rarely present with fatal necrotizing pneumonia-like features in immunosuppressed individuals, as those with chronic granulomatous disease, or patients with significant pulmonary compromise, like cystic fibrosis. CASE PRESENTATION: A 76-year-old male presented with complaints of breathlessness, cough with mucoid expectoration and fever for 3 days. He had a history of coronary artery disease, chronic obstructive pulmonary disease (COPD), diabetes mellitus and hypertension, under treatment. Pulmonary function tests were suggestive of very severe obstruction (FEV1/FVC was 55 %). So, clinical diagnosis of acute exacerbation of COPD was established. Sputum culture grew B. cepacia . The patient was treated with ceftazidime and meropenem along with inhalational bronchodilators and steroids, and showed symptomatic response to therapy. CONCLUSION: There is paucity of the literature describing B. cepacia as a potential cause for acute exacerbations in relatively common clinical conditions, such as COPD. This case report highlights the speculation of this rare possibility, thereby alerting a clinician dealing with such cases.
format Online
Article
Text
id pubmed-8208758
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Microbiology Society
record_format MEDLINE/PubMed
spelling pubmed-82087582021-06-17 Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation Ibrahim, Sufyan Madigubba, Haritha N, Himanshu Y. Chawla, Kiran Access Microbiol Case Reports INTRODUCTION: Burkholderia cepacia is an aerobic, Gram-negative bacillus, which exhibits innate resistance to multiple antibiotics and disinfectants. Although it is a chronic colonizer of the respiratory tract, it may rarely present with fatal necrotizing pneumonia-like features in immunosuppressed individuals, as those with chronic granulomatous disease, or patients with significant pulmonary compromise, like cystic fibrosis. CASE PRESENTATION: A 76-year-old male presented with complaints of breathlessness, cough with mucoid expectoration and fever for 3 days. He had a history of coronary artery disease, chronic obstructive pulmonary disease (COPD), diabetes mellitus and hypertension, under treatment. Pulmonary function tests were suggestive of very severe obstruction (FEV1/FVC was 55 %). So, clinical diagnosis of acute exacerbation of COPD was established. Sputum culture grew B. cepacia . The patient was treated with ceftazidime and meropenem along with inhalational bronchodilators and steroids, and showed symptomatic response to therapy. CONCLUSION: There is paucity of the literature describing B. cepacia as a potential cause for acute exacerbations in relatively common clinical conditions, such as COPD. This case report highlights the speculation of this rare possibility, thereby alerting a clinician dealing with such cases. Microbiology Society 2021-04-15 /pmc/articles/PMC8208758/ /pubmed/34151173 http://dx.doi.org/10.1099/acmi.0.000222 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
spellingShingle Case Reports
Ibrahim, Sufyan
Madigubba, Haritha
N, Himanshu Y.
Chawla, Kiran
Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title_full Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title_fullStr Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title_full_unstemmed Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title_short Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
title_sort burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208758/
https://www.ncbi.nlm.nih.gov/pubmed/34151173
http://dx.doi.org/10.1099/acmi.0.000222
work_keys_str_mv AT ibrahimsufyan burkholderiacepaciainfectioninanoncysticfibrosispatientanarcanepresentation
AT madigubbaharitha burkholderiacepaciainfectioninanoncysticfibrosispatientanarcanepresentation
AT nhimanshuy burkholderiacepaciainfectioninanoncysticfibrosispatientanarcanepresentation
AT chawlakiran burkholderiacepaciainfectioninanoncysticfibrosispatientanarcanepresentation